You are here: Industry Insights > Emcure

News List

Emcure Pharma appoints four new directors expresspharma
July 29, 2021
The new members’ collective strength across legal, pharma spectrum, policy developments and academics will provide additional thrust to Emcure’s growth trajectory.
Emcure Pharmaceuticals appoints Naveen Soni as Corporate Communications and Public Relations Director expresspharma
July 13, 2021
Formerly, he has also held communication portfolios in leadership positions with leading Indian MNCs such as UPL, Welspun Group, Wadia Group, Hubtown and PUG India.
Cipla, Dr Reddy’s, Emcure, Sun Pharma and Torrent to partner for clinical trial of Molnupiravir expresspharma
June 30, 2021
As per the directive of the SEC of the CDSCO, Dr Reddy’s will conduct the clinical trial and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr Reddy’s in its clinical trial.
Emcure launches India first generic version of sucroferric oxyhydroxide for chronic kidney disease patients expresspharma
July 02, 2020
Dynulta, the drug's brand name, will be manufactured at Emcure's state-of-the-art plant at Jammu and will be marketed at less than 70 per cent cost of the innovator brand.
Emcure Pharmaceuticals receives warning letter from FDA europeanpharmaceuticalreview
August 21, 2019
A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.
Emcure knocked by the FDA for sterility issues after injectable drug recall fiercepharma
August 18, 2019
Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of one of its Indian manufacturing plants. Now, it can notch one more black mark on its belt.
Emcure launches generic Eribulin for treatment of metastatic breast cancer expressbpd
April 04, 2019
The drug will be available in India at approximately 40 per cent cost of the innovator brand